The effectiveness of hyperbaric oxygen therapy on the final outcome of patients with sudden sensorineural hearing loss.

PURPOSE: To evaluate the therapeutic effect of the combination of systemic steroids (SS) and hyperbaric oxygen therapy (HBOT) in patients with idiopathic sudden sensorineural hearing loss (SSNHL). MATERIALS AND METHODS: Fifty patients with idiopathic sudden sensorineural hearing loss were allocated into 2 groups: the control group received Dexamethasone IV (SS) and the therapy group received Dexamethasone IV combined with 15 sessions of hyperbaric oxygen therapy (SS + HBOT) as initial treatment. Hearing assessment was performed at the admission to hospital and 3 months after the onset of treatment. Siegel's criteria were used to evaluate the hearing outcomes. Prognostic factors were identified by linear regression analyses. RESULTS: Hearing improvement rate was 64 % in the therapy group and 56 % in the control group, difference which was not statistically significant (p = 0.369). Furthermore, when patients of each group were categorized into 5 subgroups by disease severity (mild, moderate, moderate to severe, severe, profound), differences in treatment outcome between the subgroups of the same severity were not significant. A descending type audiogram curve was proven an unfavorable prognostic factor in both groups, as it led to a significantly lower hearing gain (30 dB) compared to other curve shapes (b = -29.10, 95 % CI = -56.39, -1.82). CONCLUSIONS: The addition of hyperbaric oxygen therapy to systemic steroids caused no significant hearing improvement, despite a mild tendency toward a greater improvement rate within the combination group. More prospective randomized trials with larger series of patients could shed even more light on the effectiveness of combination therapy (SS + HBOT) in patients affected by SSNHL.

Severe lower limb crush injury and the role of hyperbaric oxygen treatment: a case report.

Open fractures with severe soft-tissue injury and critical local ischaemia of the lower limbs are usually difficult to treat and require a multidisciplinary approach. A 33-year-old Caucasian female with crush injury of the right foot (Gustillo IIIC) was admitted to hospital after a car accident. Despite surgical interventions, a persistent state of hypoxia was present because of the severe vessel injury, and amputation was suggested. Seventy-two hours after admission she was referred to the hyperbaric medicine unit for hyperbaric oxygen treatment (HBOT) to define the limits of viable tissues prior to amputation. After six sessions, clinical improvement was so obvious that the decision to amputate was rejected and she underwent a total of 32 HBOT in addition to frequent debridement and administration of antibiotics. After the HBOT course, she underwent successful surgical reconstruction with a vascularised cutaneous flap. Full healing was achieved. Given the fact that hyperbaric oxygen mechanisms of action target the pathophysiology of crush injuries it should be considered not only for the definition of viable tissue limits but also to enhance viability, even in the most serious situations. HBOT may prove a valuable supplement in the therapeutic armamentarium of these patients.